| Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes | Hepatology | 2016 | 4.3K |
| EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease | Journal of Hepatology | 2016 | 2.1K |
| AASLD guidelines for treatment of chronic hepatitis B | Hepatology | 2016 | 1.3K |
| Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update | Hepatology International | 2016 | 1.3K |
| Bowel Disorders | Gastroenterology | 2016 | 1.3K |
| Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma | Gastroenterology | 2016 | 1K |
| Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features and Rome IV | Gastroenterology | 2016 | 939 |
| ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus | American Journal of Gastroenterology | 2016 | 928 |
| Gastroduodenal Disorders | Gastroenterology | 2016 | 746 |
| Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy | Journal of Hepatology | 2016 | 709 |
| Immunopathogenesis of IBD: current state of the art | Nature Reviews Gastroenterology and Hepatology | 2016 | 708 |
| Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells | Hepatology | 2016 | 676 |
| The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota | Hepatology | 2016 | 655 |
| Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: A meta-analysis | Journal of Hepatology | 2016 | 640 |
| Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening | Gastroenterology | 2016 | 629 |
| Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA) | Nature Reviews Gastroenterology and Hepatology | 2016 | 618 |
| Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals | Journal of Hepatology | 2016 | 612 |
| Rome IV-Functional GI Disorders: Disorders of Gut-Brain Interaction | Gastroenterology | 2016 | 598 |
| Functional Disorders: Children and Adolescents | Gastroenterology | 2016 | 580 |
| The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe | Hepatology | 2016 | 569 |
| Immunology in the liver--from homeostasis to disease | Nature Reviews Gastroenterology and Hepatology | 2016 | 514 |
| EASL Clinical Practice Guidelines: Liver transplantation | Journal of Hepatology | 2016 | 484 |
| Diet, microorganisms and their metabolites, and colon cancer | Nature Reviews Gastroenterology and Hepatology | 2016 | 478 |
| The role of the gut microbiota in NAFLD | Nature Reviews Gastroenterology and Hepatology | 2016 | 459 |
| The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults | Gastroenterology | 2016 | 443 |
